HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EWG Announces Another Reason To Become ‘EWG Verified’: Amazon.com

Executive Summary

Cosmetic products with “EWG Verified” status are being highlighted on Amazon as offerings that help to “preserve the natural world.” Consumers can look for Amazon’s “Climate Pledge Friendly” logo on product listings and visit product pages for more information on supporting certifications.

You may also be interested in...



Amazon Becomes ‘Aware,’ Launches Own Eco-Certified Skin-Care And Other Offerings

Amazon is expanding its private-label beauty portfolio with the rollout of Amazon Aware, an ‘everyday essentials’ collection comprising skin care, home and apparel items certified in accordance with its Climate Pledge Friendly program.

Is ‘Skin Deep’ Group Out Of Its Depth? EWG Announces ‘Verified’ Expansion To Cosmetic Ingredients

The Environmental Working Group is probing deeper in the supply chain to enhance its understanding of the cosmetics industry and ingredient safety underpinnings. EWG president Ken Cook and Kali Rauhe, director of cosmetic science, discuss the group’s plans for ingredient verification and greater scientific collaboration with cosmetics companies.

EU Starts On Proposal For Tackling ‘Most Harmful’ Chemicals Under Revised Cosmetics Reg

The European Commission is preparing a legal proposal to revise the Cosmetic Products Regulation in line with Green Deal objectives, including the phasing out of chemicals deemed “most harmful." Cosmetics Europe director-general John Chave discusses the problematic approach, possible impacts, and the bizarre and unintended results it could produce.

Topics

Latest News
UsernamePublicRestriction

Register

RS151550

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel